Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance

Leukemia and Lymphoma

Volumn 52, Issue 1, 2011, Pages 131-133

  Ng, Esther Shu Ting ^a   Liew, Yixin ^b   Earnest, Arul ^c   Koh, Liang Piu ^a   Lim, Siew Woon ^a   Hsu, Li Yang ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANCER CHEMOTHERAPY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTINEOPLASTIC AGENTS; BACTEREMIA; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 78651309064     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.518655     Document Type: Article

References (12)

1. Cullen M, Baijal S. Prevention of febrile neutropenia: use of prophylactic antibiotics. Br J Cancer 2009;101(Suppl. 1):S11-S14.
2. Cattaneo C, Quaresmini G, Casari S, et al. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 2008;61:721-728.
3. Kern WV, Klose K, Jellen-Ritter AS, et al. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroqui-nolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis 2005;24:111-118.
4. Hsu LY, Tan TY, Jureen R, et al. Antimicrobial drug resistance in Singapore hospitals. Emerg Infect Dis 2007;13: 1944-1947.
5. Ko WC, Hsueh PR. Increasing extended-spectrum beta-lactamase production and quinolone resistance among gram-negative bacilli causing intra-abdominal infections in the Asia/ Pacific region: data from the Smart Study 2002-2006. J Infect 2009;59:95-103.
6. Rossi F, Baquero F, Hsueh PR, et al. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006;58:205-210. (Pubitemid 44295010)
7. Aapro MS, Cameron DA, Pettengell R, et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 2006;42:2433-2453.
8. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-751.
9. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-1060.
10. Qin TJ, Mi YC, Feng SZ, et al. Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia. Zhonghua Yi Xue Za Zhi 2007;87:1389-1393.
11. Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, et al. Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City. Rev Invest Clin 2006;58:547-554.
12. European Antimicrobial Resistance Surveillance System (EARSS) Annual Report 2008 [Internet]. Bilthoven, The Netherlands, October 2009-[cited 08 July 2010]. Available from: http://www.rivm.nl/earss/Images/EARSS%25202008-final- tcm61-65020.pdf